Alka joined Mtech Access in 2023, bringing with her valuable experience from the consulting industry. Her expertise lies in conducting comprehensive and focused literature reviews across various therapeutic areas, including oncology, central nervous system, cardiovascular diseases, and rare diseases. In her previous roles, she successfully led multiple clinical, economic, epidemiology, and utility literature reviews with the specific aim of supporting HTA submissions.
Her experience extends to developing global value dossiers, AMCP dossiers, and value proposition slide decks. She possesses in-depth knowledge of the reimbursement landscape in the UK, EU4, and the US, which enables her to understand the broader significance of literature reviews within the healthcare industry.
Alka holds a Master’s degree in Pharmaceutics from NIPER, Hyderabad, India.